We use cookies to customise content for your subscription and for analytics. If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
North Carolina’s Hamner Institutes for Health Sciences and Ascletis Inc., a U.S.-China pharmaceutical company, have signed a memorandum of understanding (MOU) to support the first large-scale joint venture in biotechnology between North Carolina and China’s Zhejian Province
